Mosaic Family Wealth Partners’s Sarepta Therapeutics SRPT Stock Holding History

Mosaic Family Wealth Partners’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,969	Closed	-$361K	–	222
2024 Q4	$361K	Hold	2,969	–	–	0.05%	151
2024 Q3	$371K	Hold	2,969	–	–	0.06%	141
2024 Q2	$469K	Hold	2,969	–	–	0.08%	122
2024 Q1	$384K	Hold	2,969	–	–	0.06%	140
2023 Q4	$286K	Hold	2,969	–	–	0.05%	151
2023 Q3	$360K	Hold	2,969	–	–	0.07%	128
2023 Q2	$340K	Hold	2,969	–	–	0.07%	130
2023 Q1	$409K	Sell	2,969 -200	-6%	-$25.9K	0.09%	115
2022 Q4	$411K	Buy	+3,169	New	+$367K	0.12%	113

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mosaic Family Wealth Partners's SRPT Position: Q1 2025 in Review

Mosaic Family Wealth Partners sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,969 shares — an estimated $361K sold.

Mosaic Family Wealth Partners first reported a position in SRPT in Q4 2022 and held it in 9 quarters. The position peaked at $469K in Q2 2024. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Mosaic Family Wealth Partners reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
Mosaic Family Wealth Partners sold 2,969 Sarepta Therapeutics shares in Q1 2025, an estimated $361K.
Mosaic Family Wealth Partners first reported a position in Sarepta Therapeutics in Q4 2022 and held it in 9 quarters.
Mosaic Family Wealth Partners's Sarepta Therapeutics position peaked at $469K in Q2 2024.
431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Mosaic Family Wealth Partners's 13F filing for Q1 2025, filed 2 May 2025.